Modulation of Creutzfeldt-Jakob disease prion propagation by the A224V mutation

Annals of Neurology

Volumn 78, Issue 4, 2015, Pages 540-553

  Watts, Joel C ^a,d   Giles, Kurt ^a   Serban, Ana ^a   Patel, Smita ^a   Oehler, Abby ^b   Bhardwaj, Sumita ^a   Guan, Shenheng ^a   Greicius, Michael D ^c   Miller, Bruce L ^a   DeArmond, Stephen J ^a,b   Geschwind, Michael D ^a   Prusiner, Stanley B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c STANFORD UNIVERSITY   (United States)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PRION PROTEIN; PEPTIDE FRAGMENT; PRION; PRION PROTEIN (125-228), HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN HOMOGENATE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; DISEASE TRANSMISSION; GENE MUTATION; GENETIC POLYMORPHISM; INCUBATION TIME; MOUSE; NEUROPATHOLOGY; NONHUMAN; PRION; PRIORITY JOURNAL; RISK FACTOR; ANIMAL; BRAIN; CREUTZFELDT-JAKOB SYNDROME; FEMALE; GENETICS; HAMSTER; HUMAN; MESOCRICETUS; MIDDLE AGED; MUTATION; PATHOLOGY; TRANSGENIC MOUSE;

ANIMALS; BRAIN; CREUTZFELDT-JAKOB SYNDROME; CRICETINAE; FEMALE; HUMANS; MESOCRICETUS; MICE; MICE, TRANSGENIC; MIDDLE AGED; MUTATION; PEPTIDE FRAGMENTS; PRIONS; PRPSC PROTEINS;

EID: 84942368874     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.24463     Document Type: Article

References (49)

1. Colby DW, Prusiner SB,. Prions. Cold Spring Harb Perspect Biol 2011; 3: a006833.
2. McKinley MP, Bolton DC, Prusiner SB,. A protease-resistant protein is a structural component of the scrapie prion. Cell 1983; 35: 57-62.
3. Parchi P, Giese A, Capellari S, et al., Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 1999; 46: 224-233.
4. Bessen RA, Kocisko DA, Raymond GJ, et al., Non-genetic propagation of strain-specific properties of scrapie prion protein. Nature 1995; 375: 698-700.
5. Telling GC, Parchi P, DeArmond SJ, et al., Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity. Science 1996; 274: 2079-2082.
6. Sc types: an updated classification. Acta Neuropathol 2009; 118: 659-671.
7. Collins SJ, Sanchez-Juan P, Masters CL, et al., Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease. Brain 2006; 129: 2278-2287.
8. Korth C, Kaneko K, Groth D, et al., Abbreviated incubation times for human prions in mice expressing a chimeric mouse-human prion protein transgene. Proc Natl Acad Sci U S A 2003; 100: 4784-4789.
9. Bishop MT, Will RG, Manson JC,. Defining sporadic Creutzfeldt-Jakob disease strains and their transmission properties. Proc Natl Acad Sci U S A 2010; 107: 12005-12010.
10. Berry DB, Lu D, Geva M, et al., Drug resistance confounding prion therapeutics. Proc Natl Acad Sci U S A 2013; 110: E4160-E4169.
11. Büeler H, Fisher M, Lang Y, et al., Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 1992; 356: 577-582.
12. Watts JC, Giles K, Stöhr J, et al., Spontaneous generation of rapidly transmissible prions in transgenic mice expressing wild-type bank vole prion protein. Proc Natl Acad Sci U S A 2012; 109: 3498-3503.
13. Stanker LH, Serban AV, Cleveland E, et al., Conformation-dependent high-affinity monoclonal antibodies to prion proteins. J Immunol 2010; 185: 729-737.
14. Safar JG, Scott M, Monaghan J, et al., Measuring prions causing bovine spongiform encephalopathy or chronic wasting disease by immunoassays and transgenic mice. Nat Biotechnol 2002; 20: 1147-1150.
15. Telling GC, Scott M, Mastrianni J, et al., Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein. Cell 1995; 83: 79-90.
16. Watts JC, Giles K, Patel S, et al., Evidence that bank vole PrP is a universal acceptor for prions. PLoS Pathog 2014; 10: e1003990.
17. Zerr I, Bodemer M, Räcker S, et al., Cerebrospinal fluid concentration of neuron-specific enolase in diagnosis of Creutzfeldt-Jakob disease. Lancet 1995; 345: 1609-1610.
18. Otto M, Wiltfang J, Cepek L, et al., Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology 2002; 58: 192-197.
19. Young GS, Geschwind MD, Fischbein NJ, et al., Diffusion-weighted and fluid-attenuated inversion recovery imaging in Creutzfeldt-Jakob disease: high sensitivity and specificity for diagnosis. Am J Neuroradiol 2005; 26: 1551-1562.
20. Vitali P, Maccagnano E, Caverzasi E, et al., Diffusion-weighted MRI hyperintensity patterns differentiate CJD from other rapid dementias. Neurology 2011; 76: 1711-1719.
21. Westaway D, DeArmond SJ, Cayetano-Canlas J, et al., Degeneration of skeletal muscle, peripheral nerves, and the central nervous system in transgenic mice overexpressing wild-type prion proteins. Cell 1994; 76: 117-129.
22. Asante EA, Linehan JM, Desbruslais M, et al., BSE prions propagate as either variant CJD-like or sporadic CJD-like prion strains in transgenic mice expressing human prion protein. EMBO J 2002; 21: 6358-6366.
23. Shiga Y, Satoh K, Kitamoto T, et al., Two different clinical phenotypes of Creutzfeldt-Jakob disease with a M232R substitution. J Neurol 2007; 254: 1509-1517.
24. Beck JA, Poulter M, Campbell TA, et al., PRNP allelic series from 19 years of prion protein gene sequencing at the MRC Prion Unit. Hum Mutat 2010; 31: E1551-E1563.
25. Exome Aggregation Consortium (ExAC). Cambridge, MA: Broad Institute, 2014. Available at: http://exac.broadinstitute.org. Accessed November 25, 2014.
26. Pocchiari M, Salvatore M, Cutruzzola F, et al., A new point mutation of the prion protein gene in familial and sporadic cases of Creutzfeldt-Jakob disease. Ann Neurol 1993; 34: 802-807.
27. Spudich S, Mastrianni JA, Wrensch M, et al., Complete penetrance of Creutzfeldt-Jakob disease in Libyan Jews carrying the E200K mutation in the prion protein gene. Mol Med 1995; 1: 607-613.
28. Poduri A, Evrony GD, Cai X, Walsh CA,. Somatic mutation, genomic variation, and neurological disease. Science 2013; 341: 1237758.
29. Palmer MS, Dryden AJ, Hughes JT, Collinge J,. Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease. Nature 1991; 352: 340-342.
30. Krasnianski A, Bartl M, Sanchez Juan PJ, et al., Fatal familial insomnia: clinical features and early identification. Ann Neurol 2008; 63: 658-661.
31. Kong Q, Surewicz WK, Petersen RB, et al., Inherited prion diseases. In: Prusiner SB, ed. Prion biology and diseases, 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 2004: 673-775.
32. Nonno R, Di Bari MA, Cardone F, et al., Efficient transmission and characterization of Creutzfeldt-Jakob disease strains in bank voles. PLoS Pathog 2006; 2: e12.
33. Meissner B, Westner IM, Kallenberg K, et al., Sporadic Creutzfeldt-Jakob disease: clinical and diagnostic characteristics of the rare VV1 type. Neurology 2005; 65: 1544-1550.
34. Tanev KS, Yilma M,. An unusually presenting case of sCJD-the VV1 subtype. Clin Neurol Neurosurg 2009; 111: 282-291.
35. Watts JC, Prusiner SB,. Mouse models for studying the formation and propagation of prions. J Biol Chem 2014; 289: 19841-19849.
36. Jackson WS, Borkowski AW, Watson NE, et al., Profoundly different prion diseases in knock-in mice carrying single PrP codon substitutions associated with human diseases. Proc Natl Acad Sci U S A 2013; 110: 14759-14764.
37. Friedman-Levi Y, Meiner Z, Canello T, et al., Fatal prion disease in a mouse model of genetic E200K Creutzfeldt-Jakob disease. PLoS Pathog 2011; 7: e1002350.
38. Asante EA, Gowland I, Grimshaw A, et al., Absence of spontaneous disease and comparative prion susceptibility of transgenic mice expressing mutant human prion proteins. J Gen Virol 2009; 90: 546-558.
39. Hsiao KK, Scott M, Foster D, et al., Spontaneous neurodegeneration in transgenic mice with mutant prion protein. Science 1990; 250: 1587-1590.
40. Telling GC, Haga T, Torchia M, et al., Interactions between wild-type and mutant prion proteins modulate neurodegeneration in transgenic mice. Genes Dev 1996; 10: 1736-1750.
41. Nazor KE, Kuhn F, Seward T, et al., Immunodetection of disease-associated mutant PrP, which accelerates disease in GSS transgenic mice. EMBO J 2005; 24: 2472-2480.
42. Giles K, De Nicola GF, Patel S, et al., Identification of I137M and other mutations that modulate incubation periods for two human prion strains. J Virol 2012; 86: 6033-6041.
43. Manson JC, Jameison E, Baybutt H, et al., A single amino acid alteration (101L) introduced into murine PrP dramatically alters incubation time of transmissible spongiform encephalopathy. EMBO J 1999; 18: 6855-6864.
44. Zahn R, Liu A, Lührs T, et al., NMR solution structure of the human prion protein. Proc Natl Acad Sci U S A 2000; 97: 145-150.
45. Jansen C, Parchi P, Capellari S, et al., Prion protein amyloidosis with divergent phenotype associated with two novel nonsense mutations in PRNP. Acta Neuropathol 2010; 119: 189-197.
46. Taylor DR, Whitehouse IJ, Hooper NM,. Glypican-1 mediates both prion protein lipid raft association and disease isoform formation. PLoS Pathog 2009; 5: e1000666.
47. Deleault NR, Piro JR, Walsh DJ, et al., Isolation of phosphatidylethanolamine as a solitary cofactor for prion formation in the absence of nucleic acids. Proc Natl Acad Sci U S A 2012; 109: 8546-8551.
48. Saper CB, Wainer BH, German DC,. Axonal and transneuronal transport in the transmission of neurological disease: potential role in system degenerations, including Alzheimer's disease. Neuroscience 1987; 23: 389-398.
49. Prusiner SB,. Biology and genetics of prions causing neurodegeneration. Annu Rev Genet 2013; 47: 601-623.